aTyr Pharma announces 1-for-40 reverse stock split
ATYR•aTyr Pharma will implement a 1-for-40 reverse stock split effective at 5 p.m. ET on October 28, 2026, with split-adjusted trading beginning October 29. The split will reduce outstanding common shares from approximately 100.5 million to 2.5 million and aims to restore compliance with Nasdaq’s minimum bid price requirement.
1. Reverse split details
aTyr Pharma will implement a 1-for-40 reverse stock split effective at 5 p.m. ET on October 28, 2026. Split-adjusted trading will begin the next day on the Nasdaq Capital Market under the existing symbol ATYR. The company said the split aims to restore compliance with Nasdaq’s minimum bid price requirement; fractional shares will be rounded up to whole shares.
